Mechanical Circulatory Assistance
The European Association for Cardio-Thoracic Surgery (EACTS), The Society of Thoracic Surgeons (STS), and The American Association for Thoracic Surgery (AATS) recently released joint consensus guidelines on use of temporary mechanical circulatory support (tMCS). This...
An 8 cm left sub-areolar thoracotomy was performed as the working port. The pericardium was opened vertically over the left ventricular apex and suspended with retraction sutures. Using 3-0 polypropylene...
This retrospective observational study aimed to compare clinical outcomes and demographics of donation after circulatory death (DCD) heart transplantation (HT) between European and United States (US) centers. Analyzing 504 patients...
This multicenter cohort study evaluated the impact of preoperative temporary mechanical circulatory support (tMCS) on outcomes in patients with defined right ventricular dysfunction (RVD) undergoing HeartMate 3 left ventricular assist...
This retrospective analysis of the United Network for Organ Sharing (UNOS) database, covering the years 2019 to 2024 with a sample size of 5,325 patients, characterized the evolving landscape of...
A well-written, brief, pessimistic editorial on the loss of surgeon autonomy in innovation.
...Patient Care A professional US football player who had a congenital coronary artery anomaly corrected as a teenager meets with kids currently undergoing treatment for congenital heart disease, seeking to...
Dr Om Prakash Yadava and Professor Gino Gerosa discuss continuous flow devices compared with pulsatile flow devices and the debated issues involved. They also look at futuristic and evolving technologies...
A sobering editorial, read last May at the AATS, that discusses at length the ethics of ventricular assist as a super expensive therapy seen from the principle of fairness.
...Rajamiyer Venkateswaran of the Wythenshawe Hospital in Manchester, UK, asks whether it is possible to predict when a patient undergoing high-risk cardiac surgery will need postoperative mechanical circulatory support. He...
The Impella RP device was approved by the FDA for use as a temporary percutaneous assist for the right ventricle, as announced by Abiomed. Use is approved for up to...
A stimulating editorial triggered by tri-species autopsy work on angiodysplasia potentially attributable to continuous-flow LVAD. Dr Birks discusses the findings and appears open to the suggestion that LVAD per se...
The authors queried the UNOS heart transplantation database to determine if LVAD device-related complications (DRCs) were associated with worse postoperative graft survival. The 5 categories of DRCs were as follows:...




